This article was originally published in The Tan Sheet
Bayer stresses the importance of reading the label in a new AleveTV spot that broke Jan. 14. The ad depicts a daughter concerned about her mother's use of Aleve for arthritis. The mother responds: "I checked with my doctor [and] he said Aleve is fine for me. Just follow the directions on the label." The ad comes on the heels of a recently halted study that linked naproxen to an increased risk of cardiovascular events (1"The Tan Sheet" Jan. 3, 2005, p. 3)...
You may also be interested in...
The OTC industry is taking a wait-and-see approach regarding concerns about cardiovascular risks of naproxen (Bayer's Aleve) and other older NSAIDs rising in the wake of COX-2-related safety issues
Hopes that the Phase II TAURIEL trial could potentially validate the anti-tau antibody approach to treating Alzheimer's have been dashed as semorinemab did not meet its endpoints.
Indivior aims to cut costs by restructuring its US commercial operations and reducing discretionary spending, in order to improve flexibility in the face of the COVID-19 pandemic and to invest in R&D.